Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
October-2018 Volume 16 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2018 Volume 16 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: A case-control study

  • Authors:
    • Jie-Ming Nie
    • Hai-Feng Li
  • View Affiliations / Copyright

    Affiliations: Department of Internal Medicine, Τhe Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, P.R. China, Department of Pharmaceutical Analysis, ALK-Abello A/S Guangzhou Office, Guangzhou, Guangdong 510620, P.R. China
    Copyright: © Nie et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3405-3412
    |
    Published online on: August 24, 2018
       https://doi.org/10.3892/etm.2018.6654
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Involvement of collagen IV (ColIV) and fibronectin (FN) in the occurrence and development of diabetic nephropathy (DN) and the effects of telmisartan and Salvia miltiorrhiza injection in the treatment of the patients were investigated. Two hundred and fifty-eight patients with stage IV DN were selected as the case group, and another 110 normal healthy subjects were incorporated as the control group. Involved patients were subdivided into different groups according to different treatment therapies; patients in the telmisartan group (T group) were given oral telmisartan; patients in the Salvia miltiorrhiza injection + telmisartan (S + T group) were administered with Salvia miltiorrhiza injection combined with telmisartan treatment, and there was a group of patients who received no intervention as the placebo group. After intervention, levels of glycemic indexes and renal damage indexes indicated downwards trends both in the T group and the S + T group when compared to the placebo group; besides, levels in the S + T group were much lower than those in the T group (all P<0.05). Additionally, in comparison among the above three intervention groups, differences in the fasting blood glucose, 2 h post-prandial blood glucose, glycosylated hemoglobin, blood urea nitrogen, serum creatinine and urinary albumin excretion rate were significant after treatment (all P<0.05). Further, before intervention, both Co1IV and FN in the urine were increased in the case group compared to the control group (all P<0.05). After intervention, both levels were apparently decreased. There were remarkable differences of Co1IV and FN levels in the urine when compared among three different intervention groups after treatment (P<0.05). Increased ColIV and FN levels may be partially responsible for the development of DN. Salvia miltiorrhiza injection with telmisartan have beneficial synergistic effects for DN patients through attenuating the increase in ColIV and FN, reversing hyperglycemia state and postponing ultrastructure changes of glomerular basement membrane.
View Figures
View References

1 

Crossland L, Askew D, Ware R, Cranstoun P, Mitchell P, Bryett A and Jackson C: Diabetic retinopathy screening and monitoring of early stage disease in Australian general practice: Tackling preventable blindness within a chronic care model. J Diabetes Res. 2016:84053952016. View Article : Google Scholar : PubMed/NCBI

2 

Cobas RA, Santos B, da Silva PC, Neves R and Gomes MB: Progression to microalbuminuria in patients with type 1 diabetes: A seven-year prospective study. Diabetol Metab Syndr. 3:212011. View Article : Google Scholar : PubMed/NCBI

3 

Reutens AT and Atkins RC: Epidemiology of diabetic nephropathy. Contrib Nephrol. 170:1–7. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Van Buren PN and Toto R: Hypertension in diabetic nephropathy: Epidemiology, mechanisms, and management. Adv Chronic Kidney Dis. 18:28–41. 2011. View Article : Google Scholar : PubMed/NCBI

5 

Navarro-González JF and Mora-Fernández C: The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol. 19:433–442. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Zhou Z, Pausch F, Schlötzer-Schrehardt U, Brachvogel B and Pöschl E: Induction of initial steps of angiogenic differentiation and maturation of endothelial cells by pericytes in vitro and the role of collagen IV. Histochem Cell Biol. 145:511–525. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Behrens DT, Villone D, Koch M, Brunner G, Sorokin L, Robenek H, Bruckner-Tuderman L, Bruckner P and Hansen U: The epidermal basement membrane is a composite of separate laminin- or collagen IV-containing networks connected by aggregated perlecan, but not by nidogens. J Biol Chem. 287:18700–18709. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Rosado C, Bueno E, Fraile P, García-Cosmes P and González-Sarmiento R: A new mutation in the COL4A3 gene responsible for autosomal dominant Alport syndrome, which only generates hearing loss in some carriers. Eur J Med Genet. 58:35–38. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Yoneda Y, Haginoya K, Arai H, Yamaoka S, Tsurusaki Y, Doi H, Miyake N, Yokochi K, Osaka H, Kato M, et al: De novo and inherited mutations in COL4A2, encoding the type IV collagen α2 chain cause porencephaly. Am J Hum Genet. 90:86–90. 2012. View Article : Google Scholar : PubMed/NCBI

10 

El-Mezayen HA, Habib S, Marzok HF and Saad MH: Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: A multicenter study. Eur J Gastroenterol Hepatol. 27:378–385. 2015. View Article : Google Scholar : PubMed/NCBI

11 

Abrahamson DR, St John PL, Stroganova L, Zelenchuk A and Steenhard BM: Laminin and type IV collagen isoform substitutions occur in temporally and spatially distinct patterns in developing kidney glomerular basement membranes. J Histochem Cytochem. 61:706–718. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Ruggiero S, Cosgarea R, Potempa J, Potempa B, Eick S and Chiquet M: Cleavage of extracellular matrix in periodontitis: Gingipains differentially affect cell adhesion activities of fibronectin and tenascin-C. Biochim Biophys Acta. 1832:517–526. 2013. View Article : Google Scholar : PubMed/NCBI

13 

Halper J and Kjaer M: Basic components of connective tissues and extracellular matrix: Elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins. Adv Exp Med Biol. 802:31–47. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Kang Y, Georgiou AI, MacFarlane RJ, Klontzas ME, Heliotis M, Tsiridis E and Mantalaris A: Fibronectin stimulates the osteogenic differentiation of murine embryonic stem cells. J Tissue Eng Regen Med. 11:1929–1940. 2017. View Article : Google Scholar : PubMed/NCBI

15 

Sawicka KM, Seeliger M, Musaev T, Macri LK and Clark RA: Fibronectin interaction and enhancement of growth factors: Importance for wound healing. Adv Wound Care (New Rochelle). 4:469–478. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Linsley C, Wu B and Tawil B: The effect of fibrinogen, collagen type I, and fibronectin on mesenchymal stem cell growth and differentiation into osteoblasts. Tissue Eng Part A. 19:1416–1423. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Kenny HA, Chiang CY, White EA, Schryver EM, Habis M, Romero IL, Ladanyi A, Penicka CV, George J, Matlin K, et al: Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. J Clin Invest. 124:4614–4628. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Mòdol T, Brice N, Ruiz de Galarreta M, García Garzón A, Iraburu MJ, Martínez-Irujo JJ and López-Zabalza MJ: Fibronectin peptides as potential regulators of hepatic fibrosis through apoptosis of hepatic stellate cells. J Cell Physiol. 230:546–553. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Toledo E, Hu FB, Estruch R, Buil-Cosiales P, Corella D, Salas-Salvadó J, Covas MI, Arós F, Gómez-Gracia E, Fiol M, et al: Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: Results from a randomized controlled trial. BMC Med. 11:2072013. View Article : Google Scholar : PubMed/NCBI

20 

Xiong X, Yang X, Liu W, Chu F, Wang P and Wang J: Trends in the treatment of hypertension from the perspective of traditional Chinese medicine. Evid Based Complement Alternat Med. 2013:2752792013. View Article : Google Scholar : PubMed/NCBI

21 

Ebner T, Schänzle G, Weber W, Sent U and Elliott J: In vitro glucuronidation of the angiotensin II receptor antagonist telmisartan in the cat: A comparison with other species. J Vet Pharmacol Ther. 36:154–160. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Podymow T and Joseph G: Preconception and pregnancy management of women with diabetic nephropathy on angiotensin converting enzyme inhibitors. Clin Nephrol. 83:73–79. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Lewis G and Maxwell AP: Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? Diabetologia. 57:1082–1083. 2014. View Article : Google Scholar : PubMed/NCBI

24 

van Poppel PC, Breedveld P, Abbink EJ, Roelofs H, van Heerde W, Smits P, Lin W, Tan AH and Russel FG: Donders Ret alSalvia miltiorrhiza root water-extract (Danshen) has no beneficial effect on cardiovascular risk factors. A randomized double-blind cross-over trial. PLoS One. 10:e01286952015. View Article : Google Scholar : PubMed/NCBI

25 

Zhou X, Chan K and Yeung JH: Herb-drug interactions with Danshen (Salvia miltiorrhiza): A review on the role of cytochrome P450 enzymes. Drug Metabol Drug Interact. 27:9–18. 2012. View Article : Google Scholar : PubMed/NCBI

26 

Liu Y, Huang Y, Zhao C, Qin X, Zhu Q, Chen S and Qu J: Salvia miltiorrhiza injection on pulmonary heart disease: A systematic review and meta-analysis. Am J Chin Med. 42:1315–1331. 2014. View Article : Google Scholar : PubMed/NCBI

27 

Luo J, Song W, Yang G, Xu H and Chen K: Compound Danshen (Salvia miltiorrhiza) dripping pill for coronary heart disease: An overview of systematic reviews. Am J Chin Med. 43:25–43. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Ge G, Zhang Q, Ma J, Qiao Z, Huang J, Cheng W and Wang H: Protective effect of Salvia miltiorrhiza aqueous extract on myocardium oxidative injury in ischemic-reperfusion rats. Gene. 546:97–103. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Mogensen C: Early diabetic renal involvement and nephropathy. Diabetes Annual. 3:306–324. 1987.

30 

Upadhyaya HB, Vora MB, Nagar JG and Patel PB: Knowledge, attitude and practices toward pharmacovigilance and adverse drug reactions in postgraduate students of Tertiary Care Hospital in Gujarat. J Adv Pharm Technol Res. 6:29–34. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Goyal J, Khan ZY, Upadhyaya P, Goyal B and Jain S: Comparative study of high dose mono-therapy of amlodipine or telmisartan, and their low dose combination in mild to moderate hypertension. J Clin Diagn Res. 8:HC08–HC11. 2014.PubMed/NCBI

32 

Huang JZ, Zheng FS and Yang Y: Clinical observation of telmisartan combined with tongxinluo capsules in the treatment of early diabetic nephropathy. China Pharm. 22:1101–1103. 2011.

33 

Sato-Ηoriguchi C, Ogawa D, Wada J, Tachibana H, Kodera R, Eguchi J, Nakatsuka A, Terami N, Shikata K and Makino H: Telmisartan attenuates diabetic nephropathy by suppressing oxidative stress in db/db mice. Nephron Exp Nephrol. 121:e97–e108. 2012. View Article : Google Scholar : PubMed/NCBI

34 

Bjornstad P, Snell-Bergeon JK, Rewers M, Jalal D, Chonchol MB, Johnson RJ and Maahs DM: Early diabetic nephropathy: A complication of reduced insulin sensitivity in type 1 diabetes. Diabetes Care. 36:3678–3683. 2013. View Article : Google Scholar : PubMed/NCBI

35 

Kim BH, Lee ES, Choi R, Nawaboot J, Lee MY, Lee EY, Kim HS and Chung CH: Protective effects of curcumin on renal oxidative stress and lipid metabolism in a rat model of type 2 diabetic nephropathy. Yonsei Med J. 57:664–673. 2016. View Article : Google Scholar : PubMed/NCBI

36 

Jha JC, Gray SP, Barit D, Okabe J, El-Osta A, Namikoshi T, Thallas-Bonke V, Wingler K, Szyndralewiez C, Heitz F, et al: Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. J Am Soc Nephrol. 25:1237–1254. 2014. View Article : Google Scholar : PubMed/NCBI

37 

Sun YM, Su Y, Li J and Wang LF: Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochem Biophys Res Commun. 433:359–361. 2013. View Article : Google Scholar : PubMed/NCBI

38 

Pichaiwong W, Hudkins KL, Wietecha T, Nguyen TQ, Tachaudomdach C, Li W, Askari B, Kobayashi T, O'Brien KD, Pippin JW, et al: Reversibility of structural and functional damage in a model of advanced diabetic nephropathy. J Am Soc Nephrol. 24:1088–1102. 2013. View Article : Google Scholar : PubMed/NCBI

39 

Kolset SO, Reinholt FP and Jenssen T: Diabetic nephropathy and extracellular matrix. J Histochem Cytochem. 60:976–986. 2012. View Article : Google Scholar : PubMed/NCBI

40 

Lenihan CR, Busque S, Derby G, Blouch K, Myers BD and Tan JC: Longitudinal study of living kidney donor glomerular dynamics after nephrectomy. J Clin Invest. 125:1311–1318. 2015. View Article : Google Scholar : PubMed/NCBI

41 

Song KH, Park J, Park JH, Natarajan R and Ha H: Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice. Diabetologia. 56:1661–1669. 2013. View Article : Google Scholar : PubMed/NCBI

42 

Pieri M, Stefanou C, Zaravinos A, Erguler K, Stylianou K, Lapathitis G, Karaiskos C, Savva I, Paraskeva R, Dweep H, et al: Evidence for activation of the unfolded protein response in collagen IV nephropathies. J Am Soc Nephrol. 25:260–275. 2014. View Article : Google Scholar : PubMed/NCBI

43 

Yap WT, Salvay DM, Silliman MA, Zhang X, Bannon ZG, Kaufman DB, Lowe WL Jr and Shea LD: Collagen IV-modified scaffolds improve islet survival and function and reduce time to euglycemia. Tissue Eng Part A. 19:2361–2372. 2013. View Article : Google Scholar : PubMed/NCBI

44 

Yung S, Ng CY, Ho SK, Cheung KF, Chan KW, Zhang Q, Chau MK and Chan TM: Anti-dsDNA antibody induces soluble fibronectin secretion by proximal renal tubular epithelial cells and downstream increase of TGF-β1 and collagen synthesis. J Autoimmun. 58:111–122. 2015. View Article : Google Scholar : PubMed/NCBI

45 

Tang O, Chen XM, Shen S, Hahn M and Pollock CA: miRNA-200b represses transforming growth factor-β1-induced EMT and fibronectin expression in kidney proximal tubular cells. Am J Physiol Renal Physiol. 304:F1266–F1273. 2013. View Article : Google Scholar : PubMed/NCBI

46 

Knowles LM, Gurski LA, Maranchie JK and Pilch J: Fibronectin matrix formation is a prerequisite for colonization of kidney tumor cells in fibrin. J Cancer. 6:98–104. 2015. View Article : Google Scholar : PubMed/NCBI

47 

Liu JQ, Lee TF, Miedzyblocki M, Chan GC, Bigam DL and Cheung PY: Effects of tanshinone IIA, a major component of Salvia miltiorrhiza, on platelet aggregation in healthy newborn piglets. J Ethnopharmacol. 137:44–49. 2011. View Article : Google Scholar : PubMed/NCBI

48 

Ahn YM, Kim SK, Lee SH, Ahn SY, Kang SW, Chung JH, Kim SD and Lee BC: Renoprotective effect of Tanshinone IIA, an active component of Salvia miltiorrhiza, on rats with chronic kidney disease. Phytother Res. 24:1886–1892. 2010. View Article : Google Scholar : PubMed/NCBI

49 

Wang JG, Pimenta E and Chwallek F: Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril. Vasc Health Risk Manag. 10:189–200. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Nie J and Li H: Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: A case-control study. Exp Ther Med 16: 3405-3412, 2018.
APA
Nie, J., & Li, H. (2018). Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: A case-control study. Experimental and Therapeutic Medicine, 16, 3405-3412. https://doi.org/10.3892/etm.2018.6654
MLA
Nie, J., Li, H."Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: A case-control study". Experimental and Therapeutic Medicine 16.4 (2018): 3405-3412.
Chicago
Nie, J., Li, H."Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: A case-control study". Experimental and Therapeutic Medicine 16, no. 4 (2018): 3405-3412. https://doi.org/10.3892/etm.2018.6654
Copy and paste a formatted citation
x
Spandidos Publications style
Nie J and Li H: Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: A case-control study. Exp Ther Med 16: 3405-3412, 2018.
APA
Nie, J., & Li, H. (2018). Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: A case-control study. Experimental and Therapeutic Medicine, 16, 3405-3412. https://doi.org/10.3892/etm.2018.6654
MLA
Nie, J., Li, H."Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: A case-control study". Experimental and Therapeutic Medicine 16.4 (2018): 3405-3412.
Chicago
Nie, J., Li, H."Therapeutic effects of Salvia miltiorrhiza injection combined with telmisartan in patients with diabetic nephropathy by influencing collagen IV and fibronectin: A case-control study". Experimental and Therapeutic Medicine 16, no. 4 (2018): 3405-3412. https://doi.org/10.3892/etm.2018.6654
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team